Hey BMD
Apologies, but my read of the statement is similar to yours, but tbh I dont have the same scientific insight.
My understanding was the issue wrt hiv is the inability to clear resevoirs, right?
My take on the statement, is that 225 has at least in part achieved this?
If Im not being 'misled' by other posts here, that means this is at least a step towards removing reservoirs and immunological side affects, but potentially with varied dosage, longer duration, different circumstances, complimentary medications (dare I say it for fear of pumping) - its a cure or effective cure?
In other words, maybe it removes some % of reservoirs but not all ? Or not all at dosage within timeframe ?
Thanks in advance
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-114
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.002(7.14%) |
Mkt cap ! $23.46M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $51.84K | 1.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 198646 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 199924 | 1 |
View Market Depth
| Last trade - 15.36pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |